Search

Search Constraints

You searched for: Author/Creator Li, Hongli

Search Results

5. A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4‐dependent NLRP3 inflammasome activation. Issue 22 (17th September 2020)

7. A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806. Issue 4 (25th January 2018)

8. A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. Issue 10 (2nd October 2016)